idebenone has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idebenone was recently identified as the first small-molecule Shc inhibitor drug." | 1.62 | Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice. ( Cortopassi, G; Hui, CK; Jiang, JX; Montgomery, C; Tomilov, A; Török, NJ, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, JX | 1 |
| Tomilov, A | 1 |
| Montgomery, C | 1 |
| Hui, CK | 1 |
| Török, NJ | 1 |
| Cortopassi, G | 1 |
| Tiefenbach, J | 1 |
| Magomedova, L | 1 |
| Liu, J | 1 |
| Reunov, AA | 1 |
| Tsai, R | 1 |
| Eappen, NS | 1 |
| Jockusch, RA | 1 |
| Nislow, C | 1 |
| Cummins, CL | 1 |
| Krause, HM | 1 |
2 other studies available for idebenone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Choline Deficiency; Diet; Disease Models | 2021 |
Idebenone and coenzyme Q
Topics: 3T3-L1 Cells; Animals; Animals, Genetically Modified; Benzoquinones; Drug Evaluation, Preclinical; H | 2018 |